A Phase II Study of First-Line Afatinib for Patients Aged 75 or Older with EGFR Mutation-Positive Advanced Non-Small Cell Lung Cancer: North East Japan Study Group Trial NEJ027
Annals of Oncology(2018)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要